Quest Diagnostics
DGX
#1138
Rank
$16.31 B
Marketcap
$146.84
Share price
-1.10%
Change (1 day)
4.62%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Total debt

Total debt on the balance sheet as of March 2024 : $5.35 B

According to Quest Diagnostics 's latest financial reports the company's total debt is $5.35 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Quest Diagnostics - Total debt on balance sheet (from 2001 to 2024)

Total debt by year

Year Total debt Change
2023-12-31$5.49 B16.63%
2022-12-31$4.71 B-1.24%
2021-12-31$4.77 B-0.73%
2020-12-31$4.80 B-11.23%
2019-12-31$5.41 B35.71%
2018-12-31$3.99 B3.53%
2017-12-31$3.85 B2.42%
2016-12-31$3.76 B3.1%
2015-12-31$3.65 B-2.43%
2014-12-31$3.74 B12.3%
2013-12-31$3.33 B-0.95%
2012-12-31$3.36 B-16.42%
2011-12-31$4.02 B34.61%
2010-12-31$2.99 B-3.77%
2009-12-31$3.10 B0.78%
2008-12-31$3.08 B-12.92%
2007-12-31$3.54 B127.56%
2006-12-31$1.55 B-2.28%
2005-12-31$1.59 B44.9%
2004-12-31$1.09 B-0.35%
2003-12-31$1.10 B34.06%
2002-12-31$0.82 B0.1%
2001-12-31$0.82 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$5.96 B 11.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.96 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.60 B-88.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.25 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$1.50 B-71.91%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands